Cargando…

An Empiric Medicare Claims-Based Utilization Approach to Mitigating the Iodinated Contrast Shortage

Detalles Bibliográficos
Autores principales:	Duszak, Richard, Hemingway, Jennifer, Christensen, Eric W., Saindane, Amit M., Hughes, Danny R., Rula, Elizabeth Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Radiology 2022
Materias:	Special Communications: Iodinated Contrast Shortage
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131464/ https://www.ncbi.nlm.nih.gov/pubmed/35643182 http://dx.doi.org/10.1016/j.jacr.2022.05.012

Ejemplares similares

Rapid Response to the Acute Iodinated Contrast Shortage During the COVID-19 Pandemic: Single-Institution Experience
por: Allen, Laveil M., et al.
Publicado: (2022)

Biphasic contrast medium injection in cardiac CT: moderate versus high concentration contrast material at identical iodine flux and iodine dose
por: Rutten, Annemarieke, et al.
Publicado: (2010)

Sir Guy Calthrop's Appeal to the Medical Profession
por: Calthrop, Guy
Publicado: (1918)

Effects of an Iodine-Containing Prenatal Multiple Micronutrient on Maternal and Infant Iodine Status and Thyroid Function: A Randomized Trial in The Gambia
por: Eriksen, Kamilla G., et al.
Publicado: (2020)

Impact on clinical practice of updated guidelines on iodinated contrast material: CINART
por: Nijssen, E. C., et al.
Publicado: (2020)

Iodine Deficiency and Mortality in Spanish Adults: Di@bet.es Study
por: Maldonado-Araque, Cristina, et al.
Publicado: (2021)

Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines
por: Stacul, Fulvio, et al.
Publicado: (2017)

Household Coverage with Adequately Iodized Salt and Iodine Status of Nonpregnant and Pregnant Women in Uzbekistan
por: Rohner, Fabian, et al.
Publicado: (2020)

Estimating the Health and Economic Benefits of Universal Salt Iodization Programs to Correct Iodine Deficiency Disorders
por: Gorstein, Jonathan Louis, et al.
Publicado: (2020)

Thyroglobulin as a Functional Biomarker of Iodine Status in a Cohort Study of Pregnant Women in the United Kingdom
por: Bath, Sarah C., et al.
Publicado: (2017)

The pharmacokinetic profile, tolerability and safety of the iodinated, non-ionic, dimeric contrast medium Iosimenol 340 injection in healthy human subjects
por: Meurer, Karoline, et al.
Publicado: (2015)

Effects of Two Weekly Servings of Cod for 16 Weeks in Pregnancy on Maternal Iodine Status and Infant Neurodevelopment: Mommy's Food, a Randomized-Controlled Trial
por: Markhus, Maria Wik, et al.
Publicado: (2021)

Comparative assessment of image quality for coronary CT angiography with iobitridol and two contrast agents with higher iodine concentrations: iopromide and iomeprol. A multicentre randomized double-blind trial
por: Achenbach, Stephan, et al.
Publicado: (2016)

Intravenous contrast medium extravasation: systematic review and updated ESUR Contrast Media Safety Committee Guidelines
por: Roditi, Giles, et al.
Publicado: (2022)

Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines
por: van der Molen, Aart J., et al.
Publicado: (2018)

Ionic and non-ionic intravenous X-ray contrast media: antibacterial agents?
por: Mosler, Frank, et al.
Publicado: (2021)

Empiric ablation of asymptomatic PVCs when there is greater than 20% burden but normal left ventricular function—An argument in support of catheter ablation
por: Han, Frederick T.
Publicado: (2021)

Machine learning-based prediction of insufficient contrast enhancement in coronary computed tomography angiography
por: Lopes, R. R., et al.
Publicado: (2022)

ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents
por: Neri, E., et al.
Publicado: (2015)

Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines
por: van der Molen, Aart J., et al.
Publicado: (2018)

Minimal risk of contrast-induced kidney injury in a randomly selected cohort with mildly reduced GFR
por: Carlqvist, Jeanette, et al.
Publicado: (2020)

No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CT
por: Kooiman, Judith, et al.
Publicado: (2015)

Empiric catheter ablation of premature ventricular contractions when there is a >20% burden in an asymptomatic patient with normal left ventricular size and function—An argument for a conservative, do-less approach
por: Hoffmayer, Kurt S.
Publicado: (2021)

Contrast agent and radiation dose reduction in abdominal CT by a combination of low tube voltage and advanced image reconstruction algorithms
por: Buls, Nico, et al.
Publicado: (2014)

Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue
por: Jost, Gregor, et al.
Publicado: (2016)

Post-contrast acute kidney injury in a hospitalized population: short-, mid-, and long-term outcome and risk factors for adverse events
por: Cheng, Wei, et al.
Publicado: (2020)

Prospective multicenter assessment of patient preferences for properties of gadolinium-based contrast media and their potential socioeconomic impact in a screening breast MRI setting
por: Woolen, Sean A., et al.
Publicado: (2021)

A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol: part 2—intra-arterial administration
por: van der Molen, Aart J., et al.
Publicado: (2022)

Intra-arterial and intravenous applications of Iosimenol 340 injection, a new non-ionic, dimeric, iso-osmolar radiographic contrast medium: phase 2 experience
por: Meurer, Karoline, et al.
Publicado: (2015)

Risk of acute kidney injury after contrast-enhanced computerized tomography: a systematic review and meta-analysis of 21 propensity score–matched cohort studies
por: Obed, Mikal, et al.
Publicado: (2022)

Spontaneous Echocardiographic Contrast in Constrictive Pericarditis
por: Balakrishnan, Kuhendra, et al.
Publicado: (2017)

Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy
por: Kabeer, Muhammad Asif, et al.
Publicado: (2020)

The fate of Gd and chelate following intravenous injection of gadodiamide in rats
por: Kindberg, Grete Mørk, et al.
Publicado: (2010)

MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine
por: Brismar, Torkel B., et al.
Publicado: (2011)

MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation
por: van Kessel, C. S., et al.
Publicado: (2012)

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)
por: Deray, Gilbert, et al.
Publicado: (2012)

What Evidence Is There That Gadobutrol Causes Increasing Signal Intensity within the Dentate Nucleus and Globus Pallidus on Unenhanced T1W MRI in Patients with RRMS?
por: Agris, Jacob, et al.
Publicado: (2015)

Safety of gadoxetate disodium: results from six clinical phase IV studies in 8194 patients
por: Endrikat, Jan, et al.
Publicado: (2015)

Safety profile of gadoxetate disodium in elderly patients (≥65 years)
por: Endrikat, Jan, et al.
Publicado: (2017)

Absence of potential gadolinium toxicity symptoms following 22,897 gadoteric acid (Dotarem®) examinations, including 3,209 performed on renally insufficient individuals
por: Young, Laura K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a19mallcq257smu5l0i3bcpnbu